See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $10.9B | 8.9x | 25.3x | |
| $7.1B | 24.1x | 567.1x | |
| $2.5B | 9.5x | -1224.7x | |
| $1.6B | 5.4x | -13.0x | |
| $1.1B | 20.0x | n/a | |
| $348M | 158.7x | -10.7x | |
| $347M | n/a | n/a | |
| $183M | 3.3x | 18.5x | |
| $175M | 54.3x | -8.6x | |
| $158M | n/a | -2.4x | |
| $120M | 6.8x | 9.0x | |
| $98.9M | 11.4x | -4.9x | |
| $71.7M | n/a | n/a | |
| $55.7M | 3.1x | 16.4x | |
| $48.4M | 18.0x | -9.5x | |
| $25.1M | 26.9x | -10.8x | |
| $2.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics